1,329 calculators and references across 60 specialties, with formula confidence shown up front.
ADA 10-Year Cardiovascular Risk Model: Explanation and Clinical Context This model estimates the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) based on factors such as age, gender, race, cholesterol levels, blood pressure, diabetes status, and smoking history. It is derived from the Pooled Cohort Equations, which are widely used for cardiovascular risk assessment.
Advanced CVD Risk Model: Explanation and Clinical Context The Advanced CVD Risk Model, developed by the American Heart Association, estimates the 10-year risk of cardiovascular events in individuals aged 30–79 years without a history of cardiovascular disease. This model incorporates factors such as age, sex, race, smoking status, diabetes, systolic blood pressure, total cholesterol, and HDL cholesterol levels to pro
ApoB/ApoA1 Ratio: Explanation and Clinical Context The ApoB/ApoA1 ratio is a validated biomarker reflecting the balance between atherogenic and anti-atherogenic lipoproteins. ApoB represents the total number of atherogenic particles (including LDL, VLDL), while ApoA1 is the main protein in HDL, which is protective. A higher ApoB/ApoA1 ratio indicates a predominance of atherogenic lipoproteins and a higher risk for ca
ARIC Diabetes CVD Score: Explanation and Clinical Context The ARIC Diabetes CVD Score is a validated risk assessment tool to estimate the 10-year risk of cardiovascular disease in adults with type 2 diabetes. It was derived from the Atherosclerosis Risk in Communities (ARIC) study cohort and incorporates patient-specific variables including age, sex, systolic blood pressure, total cholesterol, HDL cholesterol, smokin
ASCVD-DM Subscore: Explanation and Clinical Context The ASCVD-DM Subscore is a clinical tool designed to estimate the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) specifically in patients with type 2 diabetes mellitus. It incorporates traditional ASCVD risk factors such as age, sex, total cholesterol, HDL cholesterol, systolic blood pressure, antihypertensive treatment, smoking status, and diabetes
Atherogenic Index of Plasma (AIP): Explanation and Clinical Context The Atherogenic Index of Plasma (AIP) is calculated as the base-10 logarithm of the ratio of plasma triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C) in mmol/L: log10(TG/HDL-C). It serves as a sensitive marker of plasma atherogenicity and is closely associated with the size of LDL particles, with higher AIP indicating a predominance